Home > > > Report Detail

Global Duck Virus Enteritis Vaccine Market Growth 2020-2025

Publisher Name :
Date: 12-Nov-2020
No. of pages: 139

According to this study, over the next five years the Duck Virus Enteritis Vaccine market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Duck Virus Enteritis Vaccine business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Duck Virus Enteritis Vaccine market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Duck Virus Enteritis Vaccine, covering the supply chain analysis, impact assessment to the Duck Virus Enteritis Vaccine market size growth rate in several scenarios, and the measures to be undertaken by Duck Virus Enteritis Vaccine companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

- Live Vaccines

- Killed Vaccines

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

- Duck

- Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- United States

- Canada

- Mexico

- Brazil

- APAC

- China

- Japan

- Korea

- Southeast Asia

- India

- Australia

- Europe

- Germany

- France

- UK

- Italy

- Russia

- Middle East & Africa

- Egypt

- South Africa

- Israel

- Turkey

- GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

- Ceva Santé Animale

- Chengdu TECBOND Biological

- Institute of Veterinary Preventive Medicine

- International Duck Research Cooperative

- Institute of Animal Health and Veterinary Biologicals

- Veterinary Research Institute

- MSD Animal Health (Merck)

- Ringpu (Tianjin)Bio-Pharmacy

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Duck Virus Enteritis Vaccine consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

- To understand the structure of Duck Virus Enteritis Vaccine market by identifying its various subsegments.

- Focuses on the key global Duck Virus Enteritis Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Duck Virus Enteritis Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the consumption of Duck Virus Enteritis Vaccine submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Global Duck Virus Enteritis Vaccine Market Growth 2020-2025

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Duck Virus Enteritis Vaccine Consumption 2015-2025
2.1.2 Duck Virus Enteritis Vaccine Consumption CAGR by Region
2.2 Duck Virus Enteritis Vaccine Segment by Type
2.2.1 Live Vaccines
2.2.2 Killed Vaccines
2.3 Duck Virus Enteritis Vaccine Consumption by Type
2.3.1 Global Duck Virus Enteritis Vaccine Consumption Market Share by Type (2015-2020)
2.3.2 Global Duck Virus Enteritis Vaccine Revenue and Market Share by Type (2015-2020)
2.3.3 Global Duck Virus Enteritis Vaccine Sale Price by Type (2015-2020)
2.4 Duck Virus Enteritis Vaccine Segment by Application
2.4.1 Duck
2.4.2 Others
2.5 Duck Virus Enteritis Vaccine Consumption by Application
2.5.1 Global Duck Virus Enteritis Vaccine Consumption Market Share by Type (2015-2020)
2.5.2 Global Duck Virus Enteritis Vaccine Value and Market Share by Type (2015-2020)
2.5.3 Global Duck Virus Enteritis Vaccine Sale Price by Type (2015-2020)

3 Global Duck Virus Enteritis Vaccine by Company
3.1 Global Duck Virus Enteritis Vaccine Sales Market Share by Company
3.1.1 Global Duck Virus Enteritis Vaccine Sales by Company (2018-2020)
3.1.2 Global Duck Virus Enteritis Vaccine Sales Market Share by Company (2018-2020)
3.2 Global Duck Virus Enteritis Vaccine Revenue Market Share by Company
3.2.1 Global Duck Virus Enteritis Vaccine Revenue by Company (2018-2020)
3.2.2 Global Duck Virus Enteritis Vaccine Revenue Market Share by Company (2018-2020)
3.3 Global Duck Virus Enteritis Vaccine Sale Price by Company
3.4 Global Duck Virus Enteritis Vaccine Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Duck Virus Enteritis Vaccine Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Duck Virus Enteritis Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Duck Virus Enteritis Vaccine by Regions
4.1 Duck Virus Enteritis Vaccine by Regions
4.2 Americas Duck Virus Enteritis Vaccine Consumption Growth
4.3 APAC Duck Virus Enteritis Vaccine Consumption Growth
4.4 Europe Duck Virus Enteritis Vaccine Consumption Growth
4.5 Middle East & Africa Duck Virus Enteritis Vaccine Consumption Growth

5 Americas
5.1 Americas Duck Virus Enteritis Vaccine Consumption by Countries
5.1.1 Americas Duck Virus Enteritis Vaccine Consumption by Countries (2015-2020)
5.1.2 Americas Duck Virus Enteritis Vaccine Value by Countries (2015-2020)
5.2 Americas Duck Virus Enteritis Vaccine Consumption by Type
5.3 Americas Duck Virus Enteritis Vaccine Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Duck Virus Enteritis Vaccine Consumption by Regions
6.1.1 APAC Duck Virus Enteritis Vaccine Consumption by Regions (2015-2020)
6.1.2 APAC Duck Virus Enteritis Vaccine Value by Regions (2015-2020)
6.2 APAC Duck Virus Enteritis Vaccine Consumption by Type
6.3 APAC Duck Virus Enteritis Vaccine Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Duck Virus Enteritis Vaccine by Countries
7.1.1 Europe Duck Virus Enteritis Vaccine Consumption by Countries (2015-2020)
7.1.2 Europe Duck Virus Enteritis Vaccine Value by Countries (2015-2020)
7.2 Europe Duck Virus Enteritis Vaccine Consumption by Type
7.3 Europe Duck Virus Enteritis Vaccine Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Duck Virus Enteritis Vaccine by Countries
8.1.1 Middle East & Africa Duck Virus Enteritis Vaccine Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Duck Virus Enteritis Vaccine Value by Countries (2015-2020)
8.2 Middle East & Africa Duck Virus Enteritis Vaccine Consumption by Type
8.3 Middle East & Africa Duck Virus Enteritis Vaccine Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Duck Virus Enteritis Vaccine Distributors
10.3 Duck Virus Enteritis Vaccine Customer

11 Global Duck Virus Enteritis Vaccine Market Forecast
11.1 Global Duck Virus Enteritis Vaccine Consumption Forecast (2021-2025)
11.2 Global Duck Virus Enteritis Vaccine Forecast by Regions
11.2.1 Global Duck Virus Enteritis Vaccine Forecast by Regions (2021-2025)
11.2.2 Global Duck Virus Enteritis Vaccine Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast byRegions
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Duck Virus Enteritis Vaccine Forecast by Type
11.8 Global Duck Virus Enteritis Vaccine Forecast by Application

12 Key Players Analysis
12.1 Ceva Santé Animale
12.1.1 Company Information
12.1.2 Duck Virus Enteritis Vaccine Product Offered
12.1.3 Ceva Santé Animale Duck Virus Enteritis Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Ceva Santé Animale Latest Developments
12.2 Chengdu TECBOND Biological
12.2.1 Company Information
12.2.2 Duck Virus Enteritis Vaccine Product Offered
12.2.3 Chengdu TECBOND Biological Duck Virus Enteritis Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Chengdu TECBOND Biological Latest Developments
12.3 Institute of Veterinary Preventive Medicine
12.3.1 Company Information
12.3.2 Duck Virus Enteritis Vaccine Product Offered
12.3.3 Institute of Veterinary Preventive Medicine Duck Virus Enteritis Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Institute of Veterinary Preventive Medicine Latest Developments
12.4 International Duck Research Cooperative
12.4.1 Company Information
12.4.2 Duck Virus Enteritis Vaccine Product Offered
12.4.3 International Duck Research Cooperative Duck Virus Enteritis Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 International Duck Research Cooperative Latest Developments
12.5 Institute of Animal Health and Veterinary Biologicals
12.5.1 Company Information
12.5.2 Duck Virus Enteritis Vaccine Product Offered
12.5.3 Institute of Animal Health and Veterinary Biologicals Duck Virus Enteritis Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Institute of Animal Health and Veterinary Biologicals Latest Developments
12.6 Veterinary Research Institute
12.6.1 Company Information
12.6.2 Duck Virus Enteritis Vaccine Product Offered
12.6.3 Veterinary Research Institute Duck Virus Enteritis Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Veterinary Research Institute Latest Developments
12.7 MSD Animal Health (Merck)
12.7.1 Company Information
12.7.2 Duck Virus Enteritis Vaccine Product Offered
12.7.3 MSD Animal Health (Merck) Duck Virus Enteritis Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 MSD Animal Health (Merck) Latest Developments
12.8 Ringpu (Tianjin)Bio-Pharmacy
12.8.1 Company Information
12.8.2 Duck Virus Enteritis Vaccine Product Offered
12.8.3 Ringpu (Tianjin)Bio-Pharmacy Duck Virus Enteritis Vaccine Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Ringpu (Tianjin)Bio-Pharmacy Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. Duck Virus Enteritis Vaccine Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Live Vaccines
Table 5. Major Players of Killed Vaccines
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Duck Virus Enteritis Vaccine Consumption Market Share by Type (2015-2020)
Table 8. Global Duck Virus Enteritis Vaccine Revenue by Type (2015-2020) ($ million)
Table 9. Global Duck Virus Enteritis Vaccine Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Duck Virus Enteritis Vaccine Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Duck Virus Enteritis Vaccine Consumption Market Share by Application (2015-2020)
Table 13. Global Duck Virus Enteritis Vaccine Value by Application (2015-2020)
Table 14. Global Duck Virus Enteritis Vaccine Value Market Share by Application (2015-2020)
Table 15. Global Duck Virus Enteritis Vaccine Sale Price by Application (2015-2020)
Table 16. Global Duck Virus Enteritis Vaccine Sales by Company (2017-2019) (K Units)
Table 17. Global Duck Virus Enteritis Vaccine Sales Market Share by Company (2017-2019)
Table 18. Global Duck Virus Enteritis Vaccine Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Duck Virus Enteritis Vaccine Revenue Market Share by Company (2017-2019)
Table 20. Global Duck Virus Enteritis Vaccine Sale Price by Company (2017-2019)
Table 21. Global Duck Virus Enteritis Vaccine Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Duck Virus Enteritis Vaccine Products Offered
Table 23. Duck Virus Enteritis Vaccine Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Duck Virus Enteritis Vaccine Consumption by Regions 2015-2020 (K Units)
Table 25. Global Duck Virus Enteritis Vaccine Consumption Market Share by Regions 2015-2020
Table 26. Global Duck Virus Enteritis Vaccine Value by Regions 2015-2020 ($ Millions)
Table 27. Global Duck Virus Enteritis Vaccine Value Market Share by Regions 2015-2020
Table 28. Americas Duck Virus Enteritis Vaccine Consumption by Countries (2015-2020) (K Units)
Table 29. Americas Duck Virus Enteritis Vaccine Consumption Market Share by Countries (2015-2020)
Table 30. Americas Duck Virus Enteritis Vaccine Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Duck Virus Enteritis Vaccine Value Market Share by Countries (2015-2020)
Table 32. Americas Duck Virus Enteritis Vaccine Consumption by Type (2015-2020) (K Units)
Table 33. Americas Duck Virus Enteritis Vaccine Consumption Market Share by Type (2015-2020)
Table 34. Americas Duck Virus Enteritis Vaccine Consumption by Application (2015-2020) (K Units)
Table 35. Americas Duck Virus Enteritis Vaccine Consumption Market Share by Application (2015-2020)
Table 36. APAC Duck Virus Enteritis Vaccine Consumption by Regions (2015-2020) (K Units)
Table 37. APAC Duck Virus Enteritis Vaccine Consumption Market Share by Regions (2015-2020)
Table 38. APAC Duck Virus Enteritis Vaccine Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Duck Virus Enteritis Vaccine Value Market Share by Regions (2015-2020)
Table 40. APAC Duck Virus Enteritis Vaccine Consumption by Type (2015-2020) (K Units)
Table 41. APAC Duck Virus Enteritis Vaccine Consumption Market Share by Type (2015-2020)
Table 42. APAC Duck Virus Enteritis Vaccine Consumption by Application (2015-2020) (K Units)
Table 43. APAC Duck Virus Enteritis Vaccine Consumption Market Share by Application (2015-2020)
Table 44. Europe Duck Virus Enteritis Vaccine Consumption by Countries (2015-2020) (K Units)
Table 45. Europe Duck Virus Enteritis Vaccine Consumption Market Share by Countries (2015-2020)
Table 46. Europe Duck Virus Enteritis Vaccine Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Duck Virus Enteritis Vaccine Value Market Share by Countries (2015-2020)
Table 48. Europe Duck Virus Enteritis Vaccine Consumption by Type (2015-2020) (K Units)
Table 49. Europe Duck Virus Enteritis Vaccine Consumption Market Share by Type (2015-2020)
Table 50. Europe Duck Virus Enteritis Vaccine Consumption by Application (2015-2020) (K Units)
Table 51. Europe Duck Virus Enteritis Vaccine Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Duck Virus Enteritis Vaccine Consumption by Countries (2015-2020) (K Units)
Table 53. Middle East & Africa Duck Virus Enteritis Vaccine Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Duck Virus Enteritis Vaccine Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Duck Virus Enteritis Vaccine Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Duck Virus Enteritis Vaccine Consumption by Type (2015-2020) (K Units)
Table 57. Middle East & Africa Duck Virus Enteritis Vaccine Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Duck Virus Enteritis Vaccine Consumption by Application (2015-2020) (K Units)
Table 59. Middle East & Africa Duck Virus Enteritis Vaccine Consumption Market Share by Application (2015-2020)
Table 60. Duck Virus Enteritis Vaccine Distributors List
Table 61. Duck Virus Enteritis Vaccine Customer List
Table 62. Global Duck Virus Enteritis Vaccine Consumption Forecast by Countries (2021-2025) (K Units)
Table 63. Global Duck Virus Enteritis Vaccine Consumption Market Forecast by Regions
Table 64. Global Duck Virus Enteritis Vaccine Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Duck Virus Enteritis Vaccine Value Market Share Forecast by Regions
Table 66. Global Duck Virus Enteritis Vaccine Consumption Forecast by Type (2021-2025) (K Units)
Table 67. Global Duck Virus Enteritis Vaccine Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Duck Virus Enteritis Vaccine Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Duck Virus Enteritis Vaccine Value Market Share Forecast by Type (2021-2025)
Table 70. Global Duck Virus Enteritis Vaccine Consumption Forecast by Application (2021-2025) (K Units)
Table 71. Global Duck Virus Enteritis Vaccine Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Duck Virus Enteritis Vaccine Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Duck Virus Enteritis Vaccine Value Market Share Forecast by Application (2021-2025)
Table 74. Ceva Santé Animale Product Offered
Table 75. Ceva Santé Animale Duck Virus Enteritis Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 76. Ceva Santé Animale Main Business
Table 77. Ceva Santé Animale Latest Developments
Table 78. Ceva Santé Animale Basic Information, Company Total Revenue (in $ million), Duck Virus Enteritis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 79. Chengdu TECBOND Biological Product Offered
Table 80. Chengdu TECBOND Biological Duck Virus Enteritis Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 81. Chengdu TECBOND Biological Main Business
Table 82. Chengdu TECBOND Biological Latest Developments
Table 83. Chengdu TECBOND Biological Basic Information, Company Total Revenue (in $ million), Duck Virus Enteritis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 84. Institute of Veterinary Preventive Medicine Product Offered
Table 85. Institute of Veterinary Preventive Medicine Duck Virus Enteritis Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 86. Institute of Veterinary Preventive Medicine Main Business
Table 87. Institute of Veterinary Preventive Medicine Latest Developments
Table 88. Institute of Veterinary Preventive Medicine Basic Information, Company Total Revenue (in $ million), Duck Virus Enteritis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 89. International Duck Research Cooperative Product Offered
Table 90. International Duck Research Cooperative Duck Virus Enteritis Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 91. International Duck Research Cooperative Main Business
Table 92. International Duck Research Cooperative Latest Developments
Table 93. International Duck Research Cooperative Basic Information, Company Total Revenue (in $ million), Duck Virus Enteritis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 94. Institute of Animal Health and Veterinary Biologicals Product Offered
Table 95. Institute of Animal Health and Veterinary Biologicals Duck Virus Enteritis Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 96. Institute of Animal Health and Veterinary Biologicals Main Business
Table 97. Institute of Animal Health and Veterinary Biologicals Latest Developments
Table 98. Institute of Animal Health and Veterinary Biologicals Basic Information, Company Total Revenue (in $ million), Duck Virus Enteritis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 99. Veterinary Research Institute Product Offered
Table 100. Veterinary Research Institute Duck Virus Enteritis Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 101. Veterinary Research Institute Main Business
Table 102. Veterinary Research Institute Latest Developments
Table 103. Veterinary Research Institute Basic Information, Company Total Revenue (in $ million), Duck Virus Enteritis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 104. MSD Animal Health (Merck) Product Offered
Table 105. MSD Animal Health (Merck) Basic Information, Company Total Revenue (in $ million), Duck Virus Enteritis Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 106. MSD Animal Health (Merck) Main Business
Table 107. MSD Animal Health (Merck) Latest Developments
Table 108. MSD Animal Health (Merck) Duck Virus Enteritis Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 109. Ringpu (Tianjin)Bio-Pharmacy Product Offered
Table 110. Ringpu (Tianjin)Bio-Pharmacy Duck Virus Enteritis Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 111. Ringpu (Tianjin)Bio-Pharmacy Main Business
Table 112. Ringpu (Tianjin)Bio-Pharmacy Latest Developments
Table 113. Ringpu (Tianjin)Bio-Pharmacy Basic Information, Company Total Revenue (in $ million), Duck Virus Enteritis Vaccine Manufacturing Base, Sales Area and Its Competitors

List of Figures

Figure 1. Picture of Duck Virus Enteritis Vaccine
Figure 2. Duck Virus Enteritis Vaccine Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Duck Virus Enteritis Vaccine Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Duck Virus Enteritis Vaccine Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Live Vaccines
Figure 7. Product Picture of Killed Vaccines
Figure 8. Global Duck Virus Enteritis Vaccine Consumption Market Share by Type (2015-2020)
Figure 9. Global Duck Virus Enteritis Vaccine Value Market Share by Type (2015-2020)
Figure 10. Duck Virus Enteritis Vaccine Consumed in Duck
Figure 11. Global Duck Virus Enteritis Vaccine Market: Duck (2015-2020) (K Units)
Figure 12. Global Duck Virus Enteritis Vaccine Market: Duck (2015-2020) ($ Millions)
Figure 13. Duck Virus Enteritis Vaccine Consumed in Others
Figure 14. Global Duck Virus Enteritis Vaccine Market: Others (2015-2020) (K Units)
Figure 15. Global Duck Virus Enteritis Vaccine Market: Others (2015-2020) ($ Millions)
Figure 16. Global Duck Virus Enteritis Vaccine Consumption Market Share by Application (2015-2020)
Figure 17. Global Duck Virus Enteritis Vaccine Value Market Share by Application (2015-2020)
Figure 18. Global Duck Virus Enteritis Vaccine Sales Market Share by Company in 2017
Figure 19. Global Duck Virus Enteritis Vaccine Sales Market Share by Company in 2019
Figure 20. Global Duck Virus Enteritis Vaccine Revenue Market Share by Company in 2017
Figure 21. Global Duck Virus Enteritis Vaccine Revenue Market Share by Company in 2019
Figure 22. Global Duck Virus Enteritis Vaccine Sale Price by Company in 2019
Figure 23. Global Duck Virus Enteritis Vaccine Consumption Market Share by Regions 2015-2020
Figure 24. Global Duck Virus Enteritis Vaccine Value Market Share by Regions 2015-2020
Figure 25. Americas Duck Virus Enteritis Vaccine Consumption 2015-2020 (K Units)
Figure 26. Americas Duck Virus Enteritis Vaccine Value 2015-2020 ($ Millions)
Figure 27. APAC Duck Virus Enteritis Vaccine Consumption 2015-2020 (K Units)
Figure 28. APAC Duck Virus Enteritis Vaccine Value 2015-2020 ($ Millions)
Figure 29. Europe Duck Virus Enteritis Vaccine Consumption 2015-2020 (K Units)
Figure 30. Europe Duck Virus Enteritis Vaccine Value 2015-2020 ($ Millions)
Figure 31. Middle East & Africa Duck Virus Enteritis Vaccine Consumption 2015-2020 (K Units)
Figure 32. Middle East & Africa Duck Virus Enteritis Vaccine Value 2015-2020 ($ Millions)
Figure 33. Americas Duck Virus Enteritis Vaccine Consumption Market Share by Countries in 2019
Figure 34. Americas Duck Virus Enteritis Vaccine Value Market Share by Countries in 2019
Figure 35. Americas Duck Virus Enteritis Vaccine Consumption Market Share by Type in 2019
Figure 36. Americas Duck Virus Enteritis Vaccine Consumption Market Share by Application in 2019
Figure 37. United States Duck Virus Enteritis Vaccine Consumption Growth 2015-2020 (K Units)
Figure 38. United States Duck Virus Enteritis Vaccine Value Growth 2015-2020 ($ Millions)
Figure 39. Canada Duck Virus Enteritis Vaccine Consumption Growth 2015-2020 (K Units)
Figure 40. Canada Duck Virus Enteritis Vaccine Value Growth 2015-2020 ($ Millions)
Figure 41. Mexico Duck Virus Enteritis Vaccine Consumption Growth 2015-2020 (K Units)
Figure 42. Mexico Duck Virus Enteritis Vaccine Value Growth 2015-2020 ($ Millions)
Figure 43. APAC Duck Virus Enteritis Vaccine Consumption Market Share by Countries in 2019
Figure 44. APAC Duck Virus Enteritis Vaccine Value Market Share by Regions in 2019
Figure 45. APAC Duck Virus Enteritis Vaccine Consumption Market Share by Type in 2019
Figure 46. APAC Duck Virus Enteritis Vaccine Consumption Market Share by Application in 2019
Figure 47. China Duck Virus Enteritis Vaccine Consumption Growth 2015-2020 (K Units)
Figure 48. China Duck Virus Enteritis Vaccine Value Growth 2015-2020 ($ Millions)
Figure 49. Japan Duck Virus Enteritis Vaccine Consumption Growth 2015-2020 (K Units)
Figure 50. Japan Duck Virus Enteritis Vaccine Value Growth 2015-2020 ($ Millions)
Figure 51. Korea Duck Virus Enteritis Vaccine Consumption Growth 2015-2020 (K Units)
Figure 52. Korea Duck Virus Enteritis Vaccine Value Growth 2015-2020 ($ Millions)
Figure 53. Southeast Asia Duck Virus Enteritis Vaccine Consumption Growth 2015-2020 (K Units)
Figure 54. Southeast Asia Duck Virus Enteritis Vaccine Value Growth 2015-2020 ($ Millions)
Figure 55. India Duck Virus Enteritis Vaccine Consumption Growth 2015-2020 (K Units)
Figure 56. India Duck Virus Enteritis Vaccine Value Growth 2015-2020 ($ Millions)
Figure 57. Australia Duck Virus Enteritis Vaccine Consumption Growth 2015-2020 (K Units)
Figure 58. Australia Duck Virus Enteritis Vaccine Value Growth 2015-2020 ($ Millions)
Figure 59. Europe Duck Virus Enteritis Vaccine Consumption Market Share by Countries in 2019
Figure 60. Europe Duck Virus Enteritis Vaccine Value Market Share by Countries in 2019
Figure 61. Europe Duck Virus Enteritis Vaccine Consumption Market Share by Type in 2019
Figure 62. Europe Duck Virus Enteritis Vaccine Consumption Market Share by Application in 2019
Figure 63. Germany Duck Virus Enteritis Vaccine Consumption Growth 2015-2020 (K Units)
Figure 64. Germany Duck Virus Enteritis Vaccine Value Growth 2015-2020 ($ Millions)
Figure 65. France Duck Virus Enteritis Vaccine Consumption Growth 2015-2020 (K Units)
Figure 66. France Duck Virus Enteritis Vaccine Value Growth 2015-2020 ($ Millions)
Figure 67. UK Duck Virus Enteritis Vaccine Consumption Growth 2015-2020 (K Units)
Figure 68. UK Duck Virus Enteritis Vaccine Value Growth 2015-2020 ($ Millions)
Figure 69. Italy Duck Virus Enteritis Vaccine Consumption Growth 2015-2020 (K Units)
Figure 70. Italy Duck Virus Enteritis Vaccine Value Growth 2015-2020 ($ Millions)
Figure 71. Russia Duck Virus Enteritis Vaccine Consumption Growth 2015-2020 (K Units)
Figure 72. Russia Duck Virus Enteritis Vaccine Value Growth 2015-2020 ($ Millions)
Figure 73. Middle East & Africa Duck Virus Enteritis Vaccine Consumption Market Share by Countries in 2019
Figure 74. Middle East & Africa Duck Virus Enteritis Vaccine Value Market Share by Countries in 2019
Figure 75. Middle East & Africa Duck Virus Enteritis Vaccine Consumption Market Share by Type in 2019
Figure 76. Middle East & Africa Duck Virus Enteritis Vaccine Consumption Market Share by Application in 2019
Figure 77. Egypt Duck Virus Enteritis Vaccine Consumption Growth 2015-2020 (K Units)
Figure 78. Egypt Duck Virus Enteritis Vaccine Value Growth 2015-2020 ($ Millions)
Figure 79. South Africa Duck Virus Enteritis Vaccine Consumption Growth 2015-2020 (K Units)
Figure 80. South Africa Duck Virus Enteritis Vaccine Value Growth 2015-2020 ($ Millions)
Figure 81. Israel Duck Virus Enteritis Vaccine Consumption Growth 2015-2020 (K Units)
Figure 82. Israel Duck Virus Enteritis Vaccine Value Growth 2015-2020 ($ Millions)
Figure 83. Turkey Duck Virus Enteritis Vaccine Consumption Growth 2015-2020 (K Units)
Figure 84. Turkey Duck Virus Enteritis Vaccine Value Growth 2015-2020 ($ Millions)
Figure 85. GCC Countries Duck Virus Enteritis Vaccine Consumption Growth 2015-2020 (K Units)
Figure 86. GCC Countries Duck Virus Enteritis Vaccine Value Growth 2015-2020 ($ Millions)
Figure 87. Global Duck Virus Enteritis Vaccine Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 88. Global Duck Virus Enteritis Vaccine Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 89. Americas Duck Virus Enteritis Vaccine Consumption 2021-2025 (K Units)
Figure 90. Americas Duck Virus Enteritis Vaccine Value 2021-2025 ($ Millions)
Figure 91. APAC Duck Virus Enteritis Vaccine Consumption 2021-2025 (K Units)
Figure 92. APAC Duck Virus Enteritis Vaccine Value 2021-2025 ($ Millions)
Figure 93. Europe Duck Virus Enteritis Vaccine Consumption 2021-2025 (K Units)
Figure 94. Europe Duck Virus Enteritis Vaccine Value 2021-2025 ($ Millions)
Figure 95. Middle East & Africa Duck Virus Enteritis Vaccine Consumption 2021-2025 (K Units)
Figure 96. Middle East & Africa Duck Virus Enteritis Vaccine Value 2021-2025 ($ Millions)
Figure 97. United States Duck Virus Enteritis Vaccine Consumption 2021-2025 (K Units)
Figure 98. United States Duck Virus Enteritis Vaccine Value 2021-2025 ($ Millions)
Figure 99. Canada Duck Virus Enteritis Vaccine Consumption 2021-2025 (K Units)
Figure 100. Canada Duck Virus Enteritis Vaccine Value 2021-2025 ($ Millions)
Figure 101. Mexico Duck Virus Enteritis Vaccine Consumption 2021-2025 (K Units)
Figure 102. Mexico Duck Virus Enteritis Vaccine Value 2021-2025 ($ Millions)
Figure 103. Brazil Duck Virus Enteritis Vaccine Consumption 2021-2025 (K Units)
Figure 104. Brazil Duck Virus Enteritis Vaccine Value 2021-2025 ($ Millions)
Figure 105. China Duck Virus Enteritis Vaccine Consumption 2021-2025 (K Units)
Figure 106. China Duck Virus Enteritis Vaccine Value 2021-2025 ($ Millions)
Figure 107. Japan Duck Virus Enteritis Vaccine Consumption 2021-2025 (K Units)
Figure 108. Japan Duck Virus Enteritis Vaccine Value 2021-2025 ($ Millions)
Figure 109. Korea Duck Virus Enteritis Vaccine Consumption 2021-2025 (K Units)
Figure 110. Korea Duck Virus Enteritis Vaccine Value 2021-2025 ($ Millions)
Figure 111. Southeast Asia Duck Virus Enteritis Vaccine Consumption 2021-2025 (K Units)
Figure 112. Southeast Asia Duck Virus Enteritis Vaccine Value 2021-2025 ($ Millions)
Figure 113. India Duck Virus Enteritis Vaccine Consumption 2021-2025 (K Units)
Figure 114. India Duck Virus Enteritis Vaccine Value 2021-2025 ($ Millions)
Figure 115. Australia Duck Virus Enteritis Vaccine Consumption 2021-2025 (K Units)
Figure 116. Australia Duck Virus Enteritis Vaccine Value 2021-2025 ($ Millions)
Figure 117. Germany Duck Virus Enteritis Vaccine Consumption 2021-2025 (K Units)
Figure 118. Germany Duck Virus Enteritis Vaccine Value 2021-2025 ($ Millions)
Figure 119. France Duck Virus Enteritis Vaccine Consumption 2021-2025 (K Units)
Figure 120. France Duck Virus Enteritis Vaccine Value 2021-2025 ($ Millions)
Figure 121. UK Duck Virus Enteritis Vaccine Consumption 2021-2025 (K Units)
Figure 122. UK Duck Virus Enteritis Vaccine Value 2021-2025 ($ Millions)
Figure 123. Italy Duck Virus Enteritis Vaccine Consumption 2021-2025 (K Units)
Figure 124. Italy Duck Virus Enteritis Vaccine Value 2021-2025 ($ Millions)
Figure 125. Russia Duck Virus Enteritis Vaccine Consumption 2021-2025 (K Units)
Figure 126. Russia Duck Virus Enteritis Vaccine Value 2021-2025 ($ Millions)
Figure 127. Spain Duck Virus Enteritis Vaccine Consumption 2021-2025 (K Units)
Figure 128. Spain Duck Virus Enteritis Vaccine Value 2021-2025 ($ Millions)
Figure 129. Egypt Duck Virus Enteritis Vaccine Consumption 2021-2025 (K Units)
Figure 130. Egypt Duck Virus Enterit
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs